GARY W PACE
CIK 1184778 · last filed 2026-07-16
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$53.88M
Companies
6
Total Filings
86
Lifetime Open-Market Net
-$18.70M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CRDF | Director | 3,389,337 | $0.82 | $2.77M | $3.97M | 20 | 2026-07-16 |
| PCRX | Director | 22,127 | $26.81 | $593.2K | -$5.22M | 25 | 2024-03-08 |
| Cardiff Oncology, Inc. (TROV) Delisted | Director | — | — | — | $0 | 1 | 2020-05-01 |
| RMD | Director | 241,736 | $208.96 | $50.51M | -$17.54M | 29 | 2018-05-10 |
| Imunon, Inc. (CLSN) Delisted | Director | 43,356 | $1.96 | $85.0K | $47.5K | 3 | 2010-02-23 |
| Imunon, Inc. (CLN) Delisted | Director | 20,349 | — | — | $37.4K | 4 | 2008-04-29 |
Recent Filings · Page 4 of 9
86 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-05-13 | CRDF | Buy (P) | +447,761 | $600.0K | EDGAR |
| 2020-05-01 | Cardiff Oncology, Inc. (TROV) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-03-16 | PCRX | Exer (M) | +21,736 | $96.8K | EDGAR |
| 2019-06-06 | PCRX | Grant (A) | +4,134 | $0 | EDGAR |
| 2018-11-21 | PCRX | Buy (P) | +4,500 | $207.8K | EDGAR |
| 2018-11-09 | PCRX | Buy (P) | +4,000 | $205.2K | EDGAR |
| 2018-06-15 | PCRX | Grant (A) | +782 | $0 | EDGAR |
| 2018-05-10 | RMD | Mixed | — | -$1.98M | EDGAR |
| 2017-11-17 | RMD | Grant (A) | +2,991 | $0 | EDGAR |
| 2017-06-16 | PCRX | Grant (A) | +1,357 | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.